BACKGROUND: Apoptosis is one of the presumptive causes of CD4+ T cell depletion during HIV infection and progression to AIDS. However, the precise role of HIV-1 in this process remains unexplained. HIV-1 protease (PR) has been suggested as a possible factor, but a direct link between HIV-1 PR enzymatic activity and apoptosis has not been established. RESULTS: Here, we show that expression of active HIV-1 PR induces death in HeLa and HEK-293 cells via the mitochondrial apoptotic pathway. This conclusion is based on in vivo observations of the direct localization of HIV-1 PR in mitochondria, a key player in triggering apoptosis. Moreover, we observed an HIV-1 PR concentration-dependent decrease in mitochondrial membrane potential and the role of HIV-1 PR in activation of caspase 9, PARP cleavage and DNA fragmentation. In addition, in vitro data demonstrated that HIV-1 PR mediates cleavage of mitochondrial proteins Tom22, VDAC and ANT, leading to release of AIF and Hsp60 proteins. By using yeast two-hybrid screening, we also identified a new HIV-1 PR interaction partner, breast carcinoma-associated protein 3 (BCA3). We found that BCA3 accelerates p53 transcriptional activity on the bax promoter, thus elevating the cellular level of pro-apoptotic Bax protein. CONCLUSION: In summary, our results describe the involvement of HIV-1 PR in apoptosis, which is caused either by a direct effect of HIV-1 PR on mitochondrial membrane integrity or by its interaction with cellular protein BCA3.

Institute of Organic Chemistry and Biochemistry Academy of Sciences of the Czech Republic v v i IOCB and Gilead Research Center Flemingovo nám 2 166 10 Prague Czech Republic

000      

00000naa a2200000 a 4500

001      

bmc15014261

003      

CZ-PrNML

005      

20240522141533.0

007      

ta

008      

150420s2014 enk f 000 0|eng||

009      

AR

024    7_

$a 10.1186/1742-4690-11-37 $2 doi

035    __

$a (PubMed)24886575

040    __

$a ABA008 $b cze $d ABA008 $e AACR2

041    0_

$a eng

044    __

$a enk

100    1_

$a Rumlová, Michaela $u Institute of Organic Chemistry and Biochemistry, Academy of Sciences of the Czech Republic, v,v,i,, IOCB & Gilead Research Center, Flemingovo nám, 2, 166 10 Prague, Czech Republic. rumlova@uochb.cas.cz.

245    10

$a HIV-1 protease-induced apoptosis / $c M. Rumlová, I. Křížová, A. Keprová, R. Hadravová, M. Doležal, K. Strohalmová, I. Pichová, M. Hájek, T. Ruml,

520    9_

$a BACKGROUND: Apoptosis is one of the presumptive causes of CD4+ T cell depletion during HIV infection and progression to AIDS. However, the precise role of HIV-1 in this process remains unexplained. HIV-1 protease (PR) has been suggested as a possible factor, but a direct link between HIV-1 PR enzymatic activity and apoptosis has not been established. RESULTS: Here, we show that expression of active HIV-1 PR induces death in HeLa and HEK-293 cells via the mitochondrial apoptotic pathway. This conclusion is based on in vivo observations of the direct localization of HIV-1 PR in mitochondria, a key player in triggering apoptosis. Moreover, we observed an HIV-1 PR concentration-dependent decrease in mitochondrial membrane potential and the role of HIV-1 PR in activation of caspase 9, PARP cleavage and DNA fragmentation. In addition, in vitro data demonstrated that HIV-1 PR mediates cleavage of mitochondrial proteins Tom22, VDAC and ANT, leading to release of AIF and Hsp60 proteins. By using yeast two-hybrid screening, we also identified a new HIV-1 PR interaction partner, breast carcinoma-associated protein 3 (BCA3). We found that BCA3 accelerates p53 transcriptional activity on the bax promoter, thus elevating the cellular level of pro-apoptotic Bax protein. CONCLUSION: In summary, our results describe the involvement of HIV-1 PR in apoptosis, which is caused either by a direct effect of HIV-1 PR on mitochondrial membrane integrity or by its interaction with cellular protein BCA3.

650    _2

$a adaptorové proteiny signální transdukční $x genetika $x metabolismus $7 D048868

650    _2

$a apoptóza $x genetika $7 D017209

650    _2

$a CD4-pozitivní T-lymfocyty $x metabolismus $7 D015496

650    _2

$a buněčné linie $7 D002460

650    _2

$a nádorové buněčné linie $7 D045744

650    _2

$a fragmentace DNA $7 D053938

650    _2

$a HEK293 buňky $7 D057809

650    _2

$a HIV infekce $x genetika $x metabolismus $7 D015658

650    _2

$a HIV-proteasa $x genetika $x metabolismus $7 D016333

650    _2

$a HIV-1 $x genetika $x metabolismus $7 D015497

650    _2

$a HeLa buňky $7 D006367

650    _2

$a lidé $7 D006801

650    _2

$a mitochondrie $x genetika $x metabolismus $7 D008928

650    _2

$a mitochondriální proteiny $x genetika $x metabolismus $7 D024101

650    _2

$a jaderné proteiny $x genetika $x metabolismus $7 D009687

650    _2

$a promotorové oblasti (genetika) $x genetika $7 D011401

650    _2

$a nádorový supresorový protein p53 $x genetika $x metabolismus $7 D016159

650    _2

$a protein X asociovaný s bcl-2 $x genetika $x metabolismus $7 D051028

655    _2

$a časopisecké články $7 D016428

655    _2

$a práce podpořená grantem $7 D013485

700    1_

$a Křížová, Ivana

700    1_

$a Keprová, Alena

700    1_

$a Hadravová, Romana

700    1_

$a Doležal, Michal $7 xx0317427

700    1_

$a Strohalmová, Karolína

700    1_

$a Pichová, Iva

700    1_

$a Hájek, Miroslav

700    1_

$a Ruml, Tomáš

773    0_

$w MED00008308 $t Retrovirology $x 1742-4690 $g Roč. 11 (2014), s. 37

856    41

$u https://pubmed.ncbi.nlm.nih.gov/24886575 $y Pubmed

910    __

$a ABA008 $b sig $c sign $y a $z 0

990    __

$a 20150420 $b ABA008

991    __

$a 20240522141528 $b ABA008

999    __

$a ok $b bmc $g 1071842 $s 897139

BAS    __

$a 3

BAS    __

$a PreBMC

BMC    __

$a 2014 $b 11 $c - $d 37 $i 1742-4690 $m Retrovirology $n Retrovirology $x MED00008308

LZP    __

$a Pubmed-20150420